Bulletin

Press Information Bureau

LSW LifeScienceWorld lost one of its initial Advisory Board Members and a well-wisher on the 6th December, 2022

December 13, 2022

WHO

WHO and football icons rally to score a goal for “Health for All” to build healthier future

December 12, 2022

Roche

Roche presents new data demonstrating the potential benefit of glofitamab and Lunsumio as fixed-duration, off-the-shelf treatment options for lymphoma

December 12, 2022

Roche

Roche’s subcutaneous crovalimab given every four weeks achieves disease control in people with PNH, a life-threatening blood condition

December 11, 2022

Roche

Interim data from phase III study presented at ASH 2022 show Hemlibra achieved meaningful bleed control in infants from birth

December 11, 2022

Press Information Bureau

Protected: 2-day National Health Ministers’ Conclave on Universal Health Coverage Day 2022 concludes in Varanasi today

December 11, 2022

WHO

EMBARGOED PRESS RELEASE: GLASS report on antimicrobial resistance: embargoed until 09:00 CET (Geneva time) on 9 December 2022

December 9, 2022

Press Information Bureau

Celebration of Universal Health Coverage (UHC) Day 2022 at Varanasi on 10th December

December 8, 2022

Roche

Roche Alzheimer’s disease Cerebrospinal Fluid (CSF) assays receive FDA clearance, supporting more accurate and timely diagnosis

December 8, 2022

WHO

WHO Member States agree to develop zero draft of legally binding pandemic accord in early 2023

December 8, 2022

WHO

WHO accelerates work on nutrition targets with new commitments

December 7, 2022

< 1 … 47 48 49 50 51 52 53 54 55 … 94 >

Bulletin

Update on status of Foreign Medical Students

Pharmaceutical Technology Upgradation Assistance Scheme for MSMEs

Update on National Family Planning Program

Update on MBBS & PG seats in Indian Medical Colleges

Guidelines for prescribing generic medicines in public hospitals

LSW LifeScienceWorld lost one of its initial Advisory Board Members and a well-wisher on the 6th December, 2022

WHO and football icons rally to score a goal for “Health for All” to build healthier future

Roche presents new data demonstrating the potential benefit of glofitamab and Lunsumio as fixed-duration, off-the-shelf treatment options for lymphoma

Roche’s subcutaneous crovalimab given every four weeks achieves disease control in people with PNH, a life-threatening blood condition

Interim data from phase III study presented at ASH 2022 show Hemlibra achieved meaningful bleed control in infants from birth

Protected: 2-day National Health Ministers’ Conclave on Universal Health Coverage Day 2022 concludes in Varanasi today

EMBARGOED PRESS RELEASE: GLASS report on antimicrobial resistance: embargoed until 09:00 CET (Geneva time) on 9 December 2022

Celebration of Universal Health Coverage (UHC) Day 2022 at Varanasi on 10th December

Roche Alzheimer’s disease Cerebrospinal Fluid (CSF) assays receive FDA clearance, supporting more accurate and timely diagnosis

WHO Member States agree to develop zero draft of legally binding pandemic accord in early 2023

WHO accelerates work on nutrition targets with new commitments

Company

Resources